A citation-based method for searching scientific literature

Farzane Amirmahani, Nasim Ebrahimi, Fatemeh Molaei, Ferdos Faghihkhorasani, Kiarash Jamshidi Goharrizi, Seyede Masoumeh Mirtaghi, Marziyeh Borjian-Boroujeni, Michael R Hamblin. Ann N Y Acad Sci 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The cellular origin and malignant transformation of Waldenström macroglobulinemia.
Bruno Paiva, Luis A Corchete, Maria-Belen Vidriales, Ramón García-Sanz, Jose J Perez, Irene Aires-Mejia, Maria-Luz Sanchez, Paloma Barcena, Diego Alignani, Cristina Jimenez,[...]. Blood 2015
41
50

High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics.
Maurizio Pellegrino, Adam Sciambi, Sebastian Treusch, Robert Durruthy-Durruthy, Kaustubh Gokhale, Jose Jacob, Tina X Chen, Jennifer A Geis, William Oldham, Jairo Matthews,[...]. Genome Res 2018
68
50

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
Christine M McMahon, Timothy Ferng, Jonathan Canaani, Eunice S Wang, Jennifer J D Morrissette, Dennis J Eastburn, Maurizio Pellegrino, Robert Durruthy-Durruthy, Christopher D Watt, Saurabh Asthana,[...]. Cancer Discov 2019
111
50

Simultaneous epitope and transcriptome measurement in single cells.
Marlon Stoeckius, Christoph Hafemeister, William Stephenson, Brian Houck-Loomis, Pratip K Chattopadhyay, Harold Swerdlow, Rahul Satija, Peter Smibert. Nat Methods 2017
628
50

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Steven P Treon, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Yang Cao, Patricia Sheehy, Robert J Manning, Christopher J Patterson, Christina Tripsas,[...]. N Engl J Med 2012
714
50

The origins and implications of intratumor heterogeneity.
Franziska Michor, Kornelia Polyak. Cancer Prev Res (Phila) 2010
113
50

Ibrutinib Monotherapy in Symptomatic, Treatment-Naïve Patients With Waldenström Macroglobulinemia.
Steven P Treon, Joshua Gustine, Kirsten Meid, Guang Yang, Lian Xu, Xia Liu, Maria Demos, Amanda Kofides, Nicholas Tsakmaklis, Jiaji G Chen,[...]. J Clin Oncol 2018
65
50

Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
Llucia Albertí-Servera, Sofie Demeyer, Inge Govaerts, Toon Swings, Jolien De Bie, Olga Gielen, Marco Brociner, Lucienne Michaux, Johan Maertens, Anne Uyttebroeck,[...]. Blood 2021
6
50

Waldenstrom macroglobulinemia: prognosis and management.
A Oza, S V Rajkumar. Blood Cancer J 2015
26
50

Characterization and generation of human definitive multipotent hematopoietic stem/progenitor cells.
Yanling Zhu, Tianyu Wang, Jiaming Gu, Ke Huang, Tian Zhang, Zhishuai Zhang, He Liu, Jun Tang, Yuchan Mai, Yanqi Zhang,[...]. Cell Discov 2020
2
50

Ibrutinib in previously treated Waldenström's macroglobulinemia.
Steven P Treon, Christina K Tripsas, Kirsten Meid, Diane Warren, Gaurav Varma, Rebecca Green, Kimon V Argyropoulos, Guang Yang, Yang Cao, Lian Xu,[...]. N Engl J Med 2015
509
50

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
50

Multidimensional study of the heterogeneity of leukemia cells in t(8;21) acute myelogenous leukemia identifies the subtype with poor outcome.
Lu Jiang, Xue-Ping Li, Yu-Ting Dai, Bing Chen, Xiang-Qin Weng, Shu-Min Xiong, Min Zhang, Jin-Yan Huang, Zhu Chen, Sai-Juan Chen. Proc Natl Acad Sci U S A 2020
5
50


C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma.
Aldo M Roccaro, Antonio Sacco, Cristina Jimenez, Patricia Maiso, Michele Moschetta, Yuji Mishima, Yosra Aljawai, Ilyas Sahin, Michelle Kuhne, Pina Cardarelli,[...]. Blood 2014
119
50

Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics.
Kiyomi Morita, Feng Wang, Katharina Jahn, Tianyuan Hu, Tomoyuki Tanaka, Yuya Sasaki, Jack Kuipers, Sanam Loghavi, Sa A Wang, Yuanqing Yan,[...]. Nat Commun 2020
34
50

Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.
Stéphanie Poulain, Christophe Roumier, Sylvie Galiègue-Zouitina, Agnès Daudignon, Charles Herbaux, Rachid Aiijou, Amélie Lainelle, Natacha Broucqsault, Elisabeth Bertrand, Salomon Manier,[...]. Am J Hematol 2013
28
50

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.
Mariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, Giorgio Corti, Giovanni Crisafulli, Leanne G Ahronian, Benedetta Mussolin, Eunice L Kwak, Michela Buscarino, Luca Lazzari,[...]. Cancer Discov 2016
222
50

Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL.
André F Rendeiro, Thomas Krausgruber, Nikolaus Fortelny, Fangwen Zhao, Thomas Penz, Matthias Farlik, Linda C Schuster, Amelie Nemc, Szabolcs Tasnády, Marienn Réti,[...]. Nat Commun 2020
23
50



Multiplexed quantification of proteins and transcripts in single cells.
Vanessa M Peterson, Kelvin Xi Zhang, Namit Kumar, Jerelyn Wong, Lixia Li, Douglas C Wilson, Renee Moore, Terrill K McClanahan, Svetlana Sadekova, Joel A Klappenbach. Nat Biotechnol 2017
278
50

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.
Sung Choe, Hongfang Wang, Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, Alice S Mims, Justin M Watts, Daniel A Pollyea,[...]. Blood Adv 2020
39
50

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma.
Niccolo Bolli, Hervé Avet-Loiseau, David C Wedge, Peter Van Loo, Ludmil B Alexandrov, Inigo Martincorena, Kevin J Dawson, Francesco Iorio, Serena Nik-Zainal, Graham R Bignell,[...]. Nat Commun 2014
501
50

Biological and clinical significance of dysplastic hematopoiesis in patients with newly diagnosed multiple myeloma.
Catarina Maia, Noemi Puig, Maria-Teresa Cedena, Ibai Goicoechea, Rafael Valdes-Mas, Iria Vazquez, Maria-Carmen Chillon, Paula Aguirre, Sarai Sarvide, Francisco Javier Gracia-Aznárez,[...]. Blood 2020
8
50

Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
Daeun Ryu, Seok Jin Kim, Yourae Hong, Areum Jo, Nayoung Kim, Hee-Jin Kim, Hae-Ock Lee, Kihyun Kim, Woong-Yang Park. Clin Cancer Res 2020
12
50

T Cell Receptor Engineered Lymphocytes for Cancer Therapy.
Meagan R Rollins, Ellen J Spartz, Ingunn M Stromnes. Curr Protoc Immunol 2020
2
50

Publisher Correction: An optimized workflow for single-cell transcriptomics and repertoire profiling of purified lymphocytes from clinical samples.
Richa Hanamsagar, Timothy Reizis, Mathew Chamberlain, Robert Marcus, Frank O Nestle, Emanuele de Rinaldis, Virginia Savova. Sci Rep 2020
3
50

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
Marzia Varettoni, Silvia Zibellini, Daniela Capello, Luca Arcaini, Davide Rossi, Cristiana Pascutto, Sara Rattotti, Silvia Mangiacavalli, Lara Pochintesta, Manuel Gotti,[...]. Leuk Lymphoma 2013
18
50

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
Elizabeth A Leadbetter, Ian R Rifkin, Andreas M Hohlbaum, Britte C Beaudette, Mark J Shlomchik, Ann Marshak-Rothstein. Nature 2002
50

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.
C Jiménez, E Sebastián, M C Chillón, P Giraldo, J Mariano Hernández, F Escalante, T J González-López, C Aguilera, A G de Coca, I Murillo,[...]. Leukemia 2013
149
50

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Roger G Owen, Steven P Treon, Ayad Al-Katib, Rafael Fonseca, Philip R Greipp, Mary L McMaster, Enrica Morra, Gerassimos A Pangalis, Jesus F San Miguel, Andrew R Branagan,[...]. Semin Oncol 2003
590
50

Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia.
Stéphanie Poulain, Christophe Roumier, Aurélie Venet-Caillault, Martin Figeac, Charles Herbaux, Guillemette Marot, Emmanuelle Doye, Elisabeth Bertrand, Sandrine Geffroy, Frédéric Lepretre,[...]. Clin Cancer Res 2016
58
50

Somatic mutations and cell identity linked by Genotyping of Transcriptomes.
Anna S Nam, Kyu-Tae Kim, Ronan Chaligne, Franco Izzo, Chelston Ang, Justin Taylor, Robert M Myers, Ghaith Abu-Zeinah, Ryan Brand, Nathaniel D Omans,[...]. Nature 2019
63
50

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
Marzia Varettoni, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso, Ester Orlandi, Maurizio Bonfichi, Manuel Gotti,[...]. Blood 2013
196
50

Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia.
Jorge J Castillo, Joshua Gustine, Kirsten Meid, Toni Dubeau, Zachary R Hunter, Steven P Treon. Am J Hematol 2016
29
50

Single-Cell Whole-Genome Amplification and Sequencing: Methodology and Applications.
Lei Huang, Fei Ma, Alec Chapman, Sijia Lu, Xiaoliang Sunney Xie. Annu Rev Genomics Hum Genet 2015
156
50

Clonal Evolution and Changes in Two AML Patients Detected with A Novel Single-Cell DNA Sequencing Platform.
Liwen Xu, Robert Durruthy-Durruthy, Dennis J Eastburn, Maurizio Pellegrino, Omid Shah, Everett Meyer, James Zehnder. Sci Rep 2019
13
50

Single-cell mutation analysis of clonal evolution in myeloid malignancies.
Linde A Miles, Robert L Bowman, Tiffany R Merlinsky, Isabelle S Csete, Aik T Ooi, Robert Durruthy-Durruthy, Michael Bowman, Christopher Famulare, Minal A Patel, Pedro Mendez,[...]. Nature 2020
46
50

Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.
Matthew T Witkowski, Igor Dolgalev, Nikki A Evensen, Chao Ma, Tiffany Chambers, Kathryn G Roberts, Sheetal Sreeram, Yuling Dai, Anastasia N Tikhonova, Audrey Lasry,[...]. Cancer Cell 2020
22
50

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.
Baidong Hou, Philippe Saudan, Gary Ott, Matthew L Wheeler, Ming Ji, Lili Kuzmich, Linda M Lee, Robert L Coffman, Martin F Bachmann, Anthony L DeFranco. Immunity 2011
151
50

Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia.
Jolien De Bie, Sofie Demeyer, Llucia Alberti-Servera, Ellen Geerdens, Heidi Segers, Michaël Broux, Kim De Keersmaecker, Lucienne Michaux, Peter Vandenberghe, Thierry Voet,[...]. Leukemia 2018
34
50

Characterisation of CD4+ T-cell subtypes using single cell RNA sequencing and the impact of cell number and sequencing depth.
James Ding, Samantha L Smith, Gisela Orozco, Anne Barton, Steve Eyre, Paul Martin. Sci Rep 2020
3
50

Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers.
Priyanka Gopal, Elif Irem Sarihan, Eui Kyu Chie, Gwendolyn Kuzmishin, Semihcan Doken, Nathan A Pennell, Daniel P Raymond, Sudish C Murthy, Usman Ahmad, Siva Raja,[...]. Nat Commun 2019
6
50

Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemia.
Stéphanie Poulain, Charles Herbaux, Elisabeth Bertrand, Audrey Decambron, Guillemette Fouquet, Eileen Boyle, Julie Gay, Salomon Manier, Patrick Duthilleul, Christophe Roumier,[...]. Clin Lymphoma Myeloma Leuk 2013
6
50

Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.
Caroline A Jefferies, Sarah Doyle, Cornelia Brunner, Aisling Dunne, Elizabeth Brint, Claudia Wietek, Eva Walch, Thomas Wirth, Luke A J O'Neill. J Biol Chem 2003
214
50

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.
Zachary R Hunter, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Yang Cao, Robert J Manning, Christina Tripsas, Christopher J Patterson, Patricia Sheehy,[...]. Blood 2014
238
50

Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia.
Jeffrey M Granja, Sandy Klemm, Lisa M McGinnis, Arwa S Kathiria, Anja Mezger, M Ryan Corces, Benjamin Parks, Eric Gars, Michaela Liedtke, Grace X Y Zheng,[...]. Nat Biotechnol 2019
63
50

Human germinal center transcriptional programs are de-synchronized in B cell lymphoma.
Pierre Milpied, Iñaki Cervera-Marzal, Marie-Laure Mollichella, Bruno Tesson, Gabriel Brisou, Alexandra Traverse-Glehen, Gilles Salles, Lionel Spinelli, Bertrand Nadel. Nat Immunol 2018
44
50

TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia.
Stéphanie Poulain, Christophe Roumier, Elisabeth Bertrand, Aline Renneville, Aurélie Caillault-Venet, Emmanuelle Doye, Sandrine Geffroy, Sheherazade Sebda, Olivier Nibourel, Morgane Nudel,[...]. Clin Cancer Res 2017
30
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.